Glucosamine Sulfate 670

by OL Olympian Labs · capsule · 100 capsules

  • On the market (NIH)
  • UPC 7 10013 00081 1
  • DSLD label 9582
  • Serving 1 to 3 capsules; amounts per 1 capsule
  • 100 servings

Glucosamine Sulfate 670 by OL Olympian Labs lists 3 ingredients, 3 with an amount per serving of 1 capsule, such as 670 mg of glucosamine sulfate 2KCL, beside 2 Nutrition Facts rows (calories, fat and the like). Its current label entered the NIH Dietary Supplement Label Database on June 1, 2012.

What is in Glucosamine Sulfate 670?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Glucosamine Sulfate 670: Supplement Facts rows against the market (DSLD label 9582, January 2026 release)
IngredientAmount% DVAmong products listing it
Sodium0 mg0%
Glucosamine Sulfate 2KCLGlucosamine Sulfate 2KCL Note: Yielding670 mgGlucosamine Sulfate in Glucosamine Sulfate 670 against 875 products0.67 g per serving; the middle half of products list 0.5 g to 1.5 g, the median 1 g.0.67 g

62% of 875 products listing glucosamine sulfate give more (median 1 g).

SodiumSodium Note: <10 ppmno amount given
Glucosamine Sulfate500 mg
Potassium Chloride170 mg

Source: NIH ODS Dietary Supplement Label Database, label 9582 (entered June 1, 2012), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 1 ingredient sits inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Glucosamine Sulfate 670's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
SUGGESTED USE: As a dietary supplement, take one (1) to three (3) capsules daily, or as directed by a healthcare professional.
Warnings
KEEP OUT OF REACH OF CHILDREN.
Allergens and what it does not contain
Sodium Free
Storage
STORE IN A COOL, DRY PLACE.

Source: label statements in DSLD label 9582.

What else is on the label?

Other ingredients: Rice Flour, Microcrystalline Cellulose, Ascorbyl Palmitate, Silica.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Since 1992 OL.

How many labels does Glucosamine Sulfate 670 have?

One label is on file, entered on June 1, 2012.

  1. Label 9582 (current) Entered June 1, 2012 · on the market · 100 capsules · UPC 7 10013 00081 1

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names OLYMPIAN LABS INCORPORATED (manufacturer), Scottsdale, AZ. All OL Olympian Labs products.

Where next?